Vaneck Biotech Etf Equity Positions Weight
| BBH Etf | USD 167.03 1.59 0.96% |
VanEck Biotech ETF fundamentals help investors to digest information that contributes to VanEck Biotech's financial success or failures. It also enables traders to predict the movement of VanEck Etf. The fundamental analysis module provides a way to measure VanEck Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VanEck Biotech etf.
VanEck |
VanEck Biotech ETF ETF Equity Positions Weight Analysis
VanEck Biotech's Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
More About Equity Positions Weight | All Equity Analysis
Stock Percentage | = | % of Equities | in the fund |
Current VanEck Biotech Equity Positions Weight | 99.96 % |
Most of VanEck Biotech's fundamental indicators, such as Equity Positions Weight, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VanEck Biotech ETF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
| Competition |
VanEck Biotech Equity Positions Weight Component Assessment
According to the company disclosure, VanEck Biotech ETF has an Equity Positions Weight of 99%. This indicator is about the same for the VanEck average (which is currently at 99.29) family and about the same as Health (which currently averages 99.95) category. The equity positions weight for all United States etfs is 89.25% lower than that of the firm.
VanEck Equity Positions Weight Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VanEck Biotech's direct or indirect competition against its Equity Positions Weight to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of VanEck Biotech could also be used in its relative valuation, which is a method of valuing VanEck Biotech by comparing valuation metrics of similar companies.VanEck Biotech is currently under evaluation in equity positions weight as compared to similar ETFs.
Fund Asset Allocation for VanEck Biotech
The fund invests 99.96% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides VanEck Biotech's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
VanEck Fundamentals
| Price To Earning | 17.66 X | |||
| Price To Book | 2.74 X | |||
| Price To Sales | 4.72 X | |||
| Beta | 0.86 | |||
| Total Asset | 478.42 M | |||
| One Year Return | 9.70 % | |||
| Three Year Return | (5.20) % | |||
| Five Year Return | 3.80 % | |||
| Ten Year Return | 3.90 % | |||
| Net Asset | 478.42 M | |||
| Last Dividend Paid | 0.47 | |||
| Equity Positions Weight | 99.96 % |
About VanEck Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VanEck Biotech ETF's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VanEck Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VanEck Biotech ETF based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:Check out VanEck Biotech Piotroski F Score and VanEck Biotech Altman Z Score analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.